Dr Paul Fields (Guy’s and St Thomas’ Hospital, London, UK) and Dr Andrew Davies (University Hospital Southampton NHS Foundation Trust, Southampton, UK) discuss developing treatments in non hodgkin lymphoma at BSH 2015.
Related Videos In Lymphoma
John Kuruvilla, ASCO20: Results of the KEYNOTE-204 Phase III Trial in Patients with cHL
John Kuruvilla joins us to discuss the presentation a the ASCO20 Virtual Meeting of the results of the KEYNOTE-204 trial, the first positive phase III trial of an anti-PD-1 therapy in patients with relapsed or refractory classical Hodgkin lymphoma. Questions 1. What are the unmet needs in the treatment of classical Hodgkin lymphoma? (0:06) 2. […]
Theodoros P Vassilakopoulos, MD, PhD, EHA 2019 – Exciting new developments in Hodgkin lymphoma
At the EHA conference in Amsterdam we are joined by Professor Theodoros P Vassilakopoulos to discuss the most exciting new developments in standards of care for Hodgkin lymphoma. Questions 1. What are the limitations of current standards of care for Hodgkin lymphoma (HL)? (0:05) 2. What is the role of brentuximab vedotin in the current […]
Andrea Gallamini, EHA 2019 – Three-year Update of the ECHELON-1 Study
We are joined by Andrea Gallamini, at EHA 2019 to discuss his presentation on frontline brentuximab vedotin with chemotherapy for stage 3/4 classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study. Questions 1. Could you tell us a little about the ECHELON-1 study and its findings? (0:05) 2. What have we learned from the 3-year […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!